How to Get Ocrevus (ocrelizumab) Covered by Aetna CVS Health in New Jersey: Appeals, Alternatives & Approval Strategies
Answer Box: Aetna CVS Health covers Ocrevus (ocrelizumab) for multiple sclerosis in New Jersey but requires prior authorization and often step therapy with preferred DMTs first. If denied, you have 180 days to appeal through two internal levels, then New Jersey's IHCAP external review (success rate ~50% for